RNA diagnostics

How Mirvie is building an RNA platform to predict pregnancy complications sooner

Personalized pregnancy care startup Mirvie is building an RNA testing platform it says will be the first to predict preeclampsia and preterm labor months before they occur. These tests are meant to help care teams to create tailored treatment plans that account for women's unique pregnancy risks.

By Katie Adams

BioPharma, Diagnostics

Cofactor Genomics acquires Narus; ups focus on RNA diagnostics

In a move that will clearly up its focus on RNA diagnostics, St. Louis-based Cofactor Genomics has acquired San Francisco's Narus Biotechnologies.

By Meghana Keshavan

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.